CD14 and neoplasm: In our setting, neither the inhibition of NKG2D in positively isolated CD56+, CD14+ or CD3+CD56- cell populations nor the inhibition of the TRAIL in positively isolated CD14+ cells had any effect on delNS1 induced tumor cell killing.